Nonalcoholic fatty liver disease (NAFLD) clinical trials
Access comprehensive clinical trial information for Nonalcoholic fatty liver disease (NAFLD) through Pure Global AI's free database. This collection includes 17 clinical trials across multiple phases including N/A, Not Applicable, Phase 2. Currently, 4 trials are actively recruiting participants.
Research for Nonalcoholic fatty liver disease (NAFLD) is being conducted in Iran, Japan, Bangladesh and 2+ other countries. Leading sponsors include Saiseikai Suita Hospital and Barij Research Center of Medicinal Herbs. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pure Global AI provides free access to 17 clinical trials studying Nonalcoholic fatty liver disease (NAFLD), aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 5+ countries.
Top research sponsors include Saiseikai Suita Hospital, Barij Research Center of Medicinal Herbs, Department of Hepatology,Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh, among others.